Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIFN alfa-2a Add-on in CHB Patients Treated With Nucleos(t)ide Analogues
NCT02644538Phase 4Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02644538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644538.